Effective assay technologies fit for large-scale population screening of type 1 diabetes
While worldwide prevention efforts for type 1 diabetes (T1D) are underway to abrogate or slow progression to diabetes, mass screening of islet autoantibodies (IAbs) in the general population is urgently needed. IAbs, the most reliable biomarkers, play an essential role in prediction and clinical dia...
Main Authors: | Xiaofan Jia, Liping Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Clinical Diabetes and Healthcare |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcdhc.2022.1034698/full |
Similar Items
-
Early autoantibody screening for type 1 diabetes: a Kuwaiti perspective on the advantages of multiplexing chemiluminescent assays
by: Fahd Al-Mulla, et al.
Published: (2023-11-01) -
Autoantibody test for type 1 diabetes in children: are there reasons to implement a screening program in the general population? A statement endorsed by the Italian Society for Paediatric Endocrinology and Diabetes (SIEDP-ISPED) and the Italian Society of Paediatrics (SIP)
by: Valentino Cherubini, et al.
Published: (2023-07-01) -
Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes
by: Janet M. Wenzlau, et al.
Published: (2023-09-01) -
The prevalence of diabetes and thyroid related autoantibodies in Sri Lankan children with type 1 diabetes and their unaffected siblings – The utility of a new screening assay
by: Navoda Atapattu, et al.
Published: (2023-02-01) -
RELATION OF ISLET CELLS ANTIBODIES AND RESIDUAL FUNCTION OF PANCREAS IN PATIENTS WITH DIABETES TYPE I
by: T. A. Tihomirova, et al.
Published: (2014-07-01)